These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2737671)

  • 1. Inactivated X chromosome fold in human leukemia and related clonal disorders.
    Avalos MR; Léonard C; Mielot F; Tchernia G
    Hum Genet; 1989 Jul; 82(4):386-8. PubMed ID: 2737671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chromosomic characteristics associated with leukemia and other hemopathies in Costa Rica].
    Castro Volio I; Montero Umaña C; Jiménez Cruz G
    Rev Biol Trop; 1993 Dec; 41(3A):385-92. PubMed ID: 7701079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes.
    Champion KM; Gilbert JG; Asimakopoulos FA; Hinshelwood S; Green AR
    Br J Haematol; 1997 Jun; 97(4):920-6. PubMed ID: 9217198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chromosomes in human leukemia.
    Sandberg AA
    Semin Hematol; 1986 Jul; 23(3):201-17. PubMed ID: 3462910
    [No Abstract]   [Full Text] [Related]  

  • 5. Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes.
    Haferlach C; Rieder H; Lillington DM; Dastugue N; Hagemeijer A; Harbott J; Stilgenbauer S; Knuutila S; Johansson B; Fonatsch C
    Genes Chromosomes Cancer; 2007 May; 46(5):494-9. PubMed ID: 17311250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A practical metaphase marker of the inactive X chromosome.
    Van Dyke DL; Flejter WL; Worsham MJ; Roberson JR; Higgins JV; Herr HM; Knuutila S; Wang N; Babu VR; Weiss L
    Am J Hum Genet; 1986 Jul; 39(1):88-95. PubMed ID: 3463206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metaphase chromosome folds and X-inactivation.
    Butler MG; Joseph GM; Dev VG
    Am J Med Genet; 1987 Mar; 26(3):565-8. PubMed ID: 3565471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse and cytogenetic evolution in myeloid neoplasms.
    Ertz-Archambault N; Kelemen K
    Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome abnormalities in secondary myelodysplastic syndromes.
    Bloomfield CD
    Scand J Haematol Suppl; 1986; 45():82-90. PubMed ID: 3515525
    [No Abstract]   [Full Text] [Related]  

  • 10. [Aberrations of chromosome 5 in myeloid malignancies with complex chromosome abnormalities].
    Liu Q; Xu W; Zhu Y; Fan L; Qiu HR; Wang R; Qiao C; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1257-60. PubMed ID: 19099622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interphase cytogenetics by fluorescent in situ hybridization (FISH) for characterization of monosomy-7-associated myeloid disorders.
    Baurmann H; Cherif D; Berger R
    Leukemia; 1993 Mar; 7(3):384-91. PubMed ID: 8445944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inverted duplication dup(1)(q32q21) as sole aberration in lymphoid and myeloid malignancies.
    Bacher U; Schnittger S; Grüneisen A; Haferlach T; Kern W; Haferlach C
    Cancer Genet Cytogenet; 2009 Jan; 188(2):108-11. PubMed ID: 19100515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonality in hematopoietic disorders.
    Hotta T
    Int J Hematol; 1997 Dec; 66(4):403-12. PubMed ID: 9479867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal development of myeloproliferative disorders: clues to hematopoietic differentiation and multistep pathogenesis of cancer.
    Raskind WH; Steinmann L; Najfeld V
    Leukemia; 1998 Feb; 12(2):108-16. PubMed ID: 9519769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetically unrelated clones in hematological neoplasms.
    Heim S; Mitelman F
    Leukemia; 1989 Jan; 3(1):6-8. PubMed ID: 2909809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human inactivated X chromosome folds in early metaphase, prometaphase, and prophase.
    Van Dyke DL; Worsham M; Weiss L
    Hum Genet; 1987 Sep; 77(1):57-9. PubMed ID: 3623560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 1 abnormalities in myeloid malignancies: a literature survey and karyotype-phenotype associations.
    Caramazza D; Hussein K; Siragusa S; Pardanani A; Knudson RA; Ketterling RP; Tefferi A
    Eur J Haematol; 2010 Mar; 84(3):191-200. PubMed ID: 20002154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic survey of sixty-one patients with preleukemic syndrome including myeloproliferative and myelodysplastic diseases.
    Palka G; Spadano A; Calabrese G; Parruti G; Guanciali Franchi P; Di Sante O; Recchia A; Di Lorenzo R; Torlontano G
    Ann Genet; 1990; 33(4):214-8. PubMed ID: 2095702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetic evidence of Y chromosome loss in male patients with hematological disorders.
    Zhang LJ; Shin ES; Yu ZX; Li SB
    Chin Med J (Engl); 2007 Nov; 120(22):2002-5. PubMed ID: 18067786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.